TDOC vs. HIMS, SGRY, HAE, MMSI, NEOG, ICUI, CERE, PINC, MDGL, and CERT
Should you be buying Teladoc Health stock or one of its competitors? The main competitors of Teladoc Health include Hims & Hers Health (HIMS), Surgery Partners (SGRY), Haemonetics (HAE), Merit Medical Systems (MMSI), Neogen (NEOG), ICU Medical (ICUI), Cerevel Therapeutics (CERE), Premier (PINC), Madrigal Pharmaceuticals (MDGL), and Certara (CERT). These companies are all part of the "medical" sector.
Teladoc Health vs.
Hims & Hers Health (NYSE:HIMS) and Teladoc Health (NYSE:TDOC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, community ranking, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.
Teladoc Health received 640 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 64.73% of users gave Teladoc Health an outperform vote while only 33.33% of users gave Hims & Hers Health an outperform vote.
45.6% of Hims & Hers Health shares are held by institutional investors. Comparatively, 84.1% of Teladoc Health shares are held by institutional investors. 35.2% of Hims & Hers Health shares are held by company insiders. Comparatively, 1.6% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Hims & Hers Health has a net margin of -12.47% compared to Teladoc Health's net margin of -567.53%. Teladoc Health's return on equity of -4.35% beat Hims & Hers Health's return on equity.
Hims & Hers Health currently has a consensus price target of $11.55, indicating a potential upside of 15.15%. Teladoc Health has a consensus price target of $34.72, indicating a potential upside of 38.71%. Given Teladoc Health's higher probable upside, analysts plainly believe Teladoc Health is more favorable than Hims & Hers Health.
Hims & Hers Health has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500.
In the previous week, Teladoc Health had 4 more articles in the media than Hims & Hers Health. MarketBeat recorded 8 mentions for Teladoc Health and 4 mentions for Hims & Hers Health. Teladoc Health's average media sentiment score of 0.83 beat Hims & Hers Health's score of 0.38 indicating that Teladoc Health is being referred to more favorably in the news media.
Hims & Hers Health has higher earnings, but lower revenue than Teladoc Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.
Summary
Teladoc Health beats Hims & Hers Health on 12 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TDOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Teladoc Health Competitors List
